Some inconsistency in the amyloidosis as a cause of inhibitory activity of human cystatin C in our mutation optimization [14] may be due to lack of the data of single-site mutation in the strand domain of the cystatin sequence. This evidence concerns the gene CST4 and amyloidosis.